Polar Asset Management Partners Inc. Myriad Genetics Inc Transaction History

Polar Asset Management Partners Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$15.26 - $23.75 $1.62 Million - $2.52 Million	-106,300 Reduced 39.03%	166,057 $3.86 Million
Q4 2022 Feb 14, 2023	SELL	$14.51 - $20.99 $10.2 Million - $14.8 Million	-702,800 Reduced 72.07%	272,357 $3.95 Million
Q3 2022 Nov 14, 2022	SELL	$18.21 - $27.88 $3.73 Million - $5.71 Million	-204,900 Reduced 17.36%	975,157 $18.6 Million
Q2 2022 Aug 15, 2022	BUY	$16.45 - $25.88 $17.5 Million - $27.5 Million	1,063,020 Added 908.28%	1,180,057 $21.4 Million
Q1 2022 May 16, 2022	BUY	$22.67 - $28.01 $2.65 Million - $3.28 Million	117,037 New	117,037 $2.95 Million
Q4 2021 Feb 14, 2022	SELL	$24.13 - $32.63 $14.3 Million - $19.3 Million	-591,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$29.97 - $36.66 $17.7 Million - $21.7 Million	591,000 New	591,000 $19.1 Million

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.23B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

Stay updated on Polar Asset Management Partners Inc. with notifications on news.